Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Lancet
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts Nat Commun
Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum Alzheimers Dement
Novel prognostic factors and therapeutic advances in adult acute lymphoblastic leukemia LEUKEMIA LYMPHOMA
Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy CANCER-AM CANCER SOC
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial Lancet Haematol